KIF5A and amyotrophic lateral sclerosis: Interestingly, the presence of this mutated C terminal appears to be sufficient to induce the aggregation of KIF5A, indicating a toxic gain-of-function as pathological mechanism specifically characterizing these ALS cases (Nakano et al., 2022).